Chemokine score is a novel biomarker for lupus patients with active diseases and organ damages
- VernacularTitle:趋化因子积分是系统性红斑狼疮活动和损伤的生物标志物
- Author:
Qiong FU
;
Xiooqing CHEN
;
Huijuan CUI
;
Yanzhi GUO
;
Nan SHEN
;
Chunde BAO
- Publication Type:Journal Article
- Keywords:
Lupus erythematosus,systemic;
Chemokines;
Biological markers
- From:
Chinese Journal of Rheumatology
2008;12(12):803-807
- CountryChina
- Language:Chinese
-
Abstract:
Objective To correlate the chemokine score with disease activity,organ damages and clinical features in systemic lupus erythematosus (SLE) patients.Methods Peripheral blood cells obtained from 60 SLE patients,20 rheumatoid arthritis (RA) patients and 23 healthy donors (HDs) were subjected to real-time PCR to measure the transcriptional levels of seven chemokines (RANTES,MCP-1,CCL19,MIG,IP-10,CXCL11,and IL-8).Chemokine scores were calculated and were compared between various groups of SLE patients as well as between patients and controls.Results Chemokine scores were significantly elevated in SLE patients compared with RA patients and HDs (P=0.0112 and P=0.0019,respectively).Chemokine scores were correlated positively with SLEDAI (P=0.0061) and negatively with C3 levels (P=0.003).Compared to patients without lupus nephritis (LN),chemokine scores were elevated in SLE patients with active LN,especially when their daily prednisone dosage was less than 30 mg (P=0.0418 and P=0.002,respectively).Chemokine scores were also associated with cumulative organ damage (SLICC damage index [SDI]＞0) and positive anti-Sm and anti-RNP autoantibodies.Conclusion The chemokine score may serve as a new biomarker for disease activity and organ damage in SLE patients.
